BioMarin Pharmaceutical Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $598.0M | $408.3M | $397.0M | $875.5M | $568.8M | $180.5M | $46.3M | $88.1M |
| Accounts Receivable | $261.4M | $215.3M | $165.0M | $144.5M | $117.8M | $109.1M | $104.8M | $86.6M |
| Inventory | $475.8M | $355.1M | $271.7M | $199.5M | $162.6M | $128.7M | $130.1M | $109.7M |
| Total Current Assets | $2.21B | $1.42B | $1.09B | $1.40B | $1.14B | $743.4M | $469.8M | $504.3M |
| Property, Plant & Equipment | $896.7M | $798.8M | $704.2M | $523.5M | $319.3M | $284.5M | $269.0M | $221.9M |
| Goodwill | $197.0M | $197.0M | $197.0M | $54.3M | $54.3M | $51.5M | $51.5M | $53.4M |
| Intangible Assets (Excl. Goodwill) | $517.5M | $553.8M | $684.0M | $156.6M | $163.1M | $163.0M | $180.3M | $103.6M |
| Total Assets | $4.63B | $4.02B | $3.73B | $2.48B | $2.24B | $1.57B | $1.31B | $1.26B |
| Liabilities | ||||||||
| Accounts Payable | $401.9M | $370.5M | $392.5M | $32.8M | $36.9M | $24.0M | $12.2M | $5.0M |
| Total Current Liabilities | $816.5M | $439.3M | $445.5M | $235.7M | $183.3M | $170.4M | $94.1M | $83.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $1.82B | $1.26B | $1.33B | $947.5M | $903.0M | $552.6M | $532.7M | $545.4M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.64B | $-1.52B | $-1.02B | $-849.8M | $-715.8M | $-539.4M | $-425.1M | $-371.3M |
| Total Stockholders' Equity | $2.81B | $2.77B | $2.40B | $1.53B | $1.34B | $1.02B | $773.0M | $717.3M |